백급 추출물과 그 성분의 타우 과인산화 억제 효과
Bletilla striata Reichenbach, a member of the Orchidaceae family has traditionally been used for wound healing, hemostasis, and reducing swelling due to its astringent properties. In this study, the 70% ethanol extract of B. striata tubers significantly reduced okadaic acid-induced tau hyperphosphor...
Gespeichert in:
Veröffentlicht in: | 생약학회지(Korean Journal of Pharmacognosy) 2024, 55(3), 218, pp.160-166 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | kor |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Bletilla striata Reichenbach, a member of the Orchidaceae family has traditionally been used for wound healing, hemostasis, and reducing swelling due to its astringent properties. In this study, the 70% ethanol extract of B. striata tubers significantly reduced okadaic acid-induced tau hyperphosphorylation in HT22 cells, as determined by western blot analysis. Tau hyperphosphorylation is considered one of major contributors to Alzheimer' disease. The dichloromethane-partitioned fraction of the B. striata extract, which exhibited the strongest activity, was subjected to bioassay-guided isolation using various column chromatography techniques. This process led to the isolation and identification of three compounds: 3,7-dihydroxy-2,4-dimethoxyphenanthrene (1), coelonin (2) and 4-hydroxybenzyl-4,7-dimethoxy-9,10-dihydrophenanthrene-2-ol (3). All three compounds reduced tau hyperphosphorylation in a dose-dependent manner without exhibiting cytotoxicity. Notably, 4-hydroxybenzyl-4,7-dimethoxy-9,10-dihydrophenanthrene-2-ol (3) at 15 μg/mL significantly reduced tau hyperphosphorylation to 60% of the levels observed in the okadaic acid-only treated control group. These results suggest that B. striata extract and its active compounds may offer potential therapeutic benefits against Alzheimer’s disease by inhibiting tau hyperphosphorylation. KCI Citation Count: 0 |
---|---|
ISSN: | 0253-3073 2288-9299 |
DOI: | 10.22889/KJP.2024.55.3.160 |